COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 764: Articles 7631-7640  | Next

Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chaguza, C., Hahn, A. M., Petrone, M. E., Zhou, S., Ferguson, D., Breban, M. I., Pham, K., Pena-Hernandez, M. A., Castaldi, C., Hill, V., Yale SARS-CoV-2 Genomic Surveillance Initiative, , Schulz, W. L., Swanstrom, R. I., Roberts, S. C., Grubaugh, N. D.
10.1101/2022.06.29.22276868 — Posted: 2022-07-02
Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
Tannous, J., Pan, A., Potter, T., Bako, A., Dlouhy, K., Drews, A., Sostman, H. D., Vahidy, F.
10.1101/2022.06.30.22277105 — Posted: 2022-07-02
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
Polvere, J., Fabbiani, M., Pastore, G., Rancan, I., Rossetti, B., Durante, M., Zirpoli, S., Morelli, E., Pettini, E., Lucchesi, S., Fiorino, F., Tumbarello, M., Ciabattini, A., Montagnani, F., Medaglini, D.
10.1101/2022.07.01.22277132 — Posted: 2022-07-02
CovidOutcome2: a tool for SARS-CoV2 mutation identification and for disease severity prediction
Kalcsevszki, R., Horvath, A., Gyorffy, B., Pongor, S., Ligeti, B.
10.1101/2022.07.01.496571 — Posted: 2022-07-01
Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children
Lambert, N., Jonas, K.-O. A., Rissy, W. M., Diane, U., Murithi, K., Peter, K., Awe, O. I., Dillman, A.
10.1101/2022.06.30.498338 — Posted: 2022-07-01
Teaching the Skills and Concepts of Gene Expression Analysis during COVID-19
Roberts, L. A., Shell, S. S.
10.1101/2022.06.28.497969 — Posted: 2022-06-30
Identification and Mechanistic Basis of non-ACE2 Blocking Neutralizing Antibodies from COVID-19 Patients with Deep RNA Sequencing and Molecular Dynamics Simulations
Fredericks, A. M., East, K. W., Shi, Y., Liu, J., Maschietto, F., Ayala, A., Cioffi, W. G., Cohen, M., Fairbrother, W. G., Lefort, C. T., Nau, G. J., Levy, M. M., Wang, J., Batista, V. S., Lisi, G. P., Monaghan, S. F.
10.1101/2022.06.29.498206 — Posted: 2022-06-30
Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes
Giurini, E. F., Williams, M., Morin, A., Zloza, A., Gupta, K. H.
10.1101/2022.06.30.498305 — Posted: 2022-06-30
Influenza and pneumococcal vaccination and the risk of COVID-19: A systematic review and meta-analysis
Kapoula, G. V., Vennou, K. E., Bagos, P. G.
10.1101/2022.06.30.22277089 — Posted: 2022-06-30
The Citation of Retracted COVID-19 Papers is Common and Rarely Critical
Meyerowitz-Katz, G., Sekhar, P., Besancon, L., Turner, T., McDonald, S.
10.1101/2022.06.30.22277084 — Posted: 2022-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).